Concept to Cure: Latest Breakthroughs in Metastatic Breast Cancer

 

Wed., Feb. 28th, 2018 | 7:30 a.m.- 12:00 p.m. | Sanford Consortium for Regenerative Medicine 

Join Susan G. Komen® San Diego and our partners, Bank of America and Salk Women & Science for our first annual Metastatic Breast Cancer Conference – Concept to Cure. The conference, will be held on February 28th, 2018 at the Sanford Consortium for Regenerative Medicine from 7:30 to noon and will bring together leading experts in the metastatic breast cancer research field with researchers, medical professionals and representatives from local area pharmaceutical and biotech companies. Featuring presentations by Dr. Jay Desgrosellier of UC San Diego, Dr. Barbara Parker, Medical Director at UC San Diego Moores Cancer Center and Dr. Geoff Wahl of the Salk Institute.

If you are a biomedical researcher, medical professional, pharmaceutical or biotechnology representative or you’re simply interested in learning about the latest in metastatic breast cancer research we encourage you to attend.

This event is FREE however space is limited, please RSVP to let us know you will be attending.

RSVP

 

PRESENTERS

JAY DESGROSELLIER, Ph.D. 

Assistant Professor, UC San Diego Deptartment of Pathology
and Susan G. Komen Funded Researcher 

Dr. Desgrosellier will share a new therapeutic approach that could stop breast cancer metastasis from forming and spreading—rare stem-like tumor cells play a critical role in the spread of breast cancer, but a vulnerability in the pathway that powers them offers a strategy to target these cells using existing drugs before metastatic disease occurs.

VIEW FULL BIO

BARBARA PARKER, M.D.

Senior Deputy Director, Cancer Medicine Medical Director, Oncology Services,
Prof. of Medicine, Division of Hematology/Oncology
UC San Diego Moores Cancer Center

Dr. Parker will discuss the “Personalized Approaches to Prevent and Treat Advanced Breast Cancer.” Her presentation will coverClinical challenges of tumor heterogeneity – subtypes and unique mutational profiles (“snowflakes”); personalized approaches to screening and prevention; the best way to cure cancer is to prevent it, progress in using the neoadjuvant setting to determine novel drug activity and molecular Tumor Boards and personalized targeted therapy.

VIEW FULL BIO

GEOFFREY M. WAHL, Ph.D. 

Salk Institute (NCI)-designated basic research cancer center
Professor, Gene Expression
Laboratory,  Adjunct Professor at UCSD and Komen Scholar. 

Dr. Wahl will present a brief overview of metastasis and its complexities. Wahl will also present on intratumoral heterogeneity and how it arises. Lastly he will discuss how tumor cells can reprogram to a very plastic state which, by the action of one transcription factor that is regulated by paracrine factors such as FGF, can reversibly produce motile, invasive cells that acquire a neural crest like state from transformed mammary cells.

VIEW FULL BIO
CONFERENCE HIGHLIGHTS

NEW Breakthrough therapeutic approach that could stop breast cancer metastasis from forming

 

Integration of research and clinical practice

 

Importance of clinical trials

2018 SPONSORS

 

PRESENTING SPONSOR

 

CONFERENCE EXHIBITION SPONSOR

 

PROGRAM SPONSORS

 

CONFERENCE PARTNER

For more information, please contact Judi Steadman.

 

Details

Starts On

February 28, 2018 - 7:30 am

Ends On

12:00 pm

Venue

Sanford Consortium for Regenerative Medicine

2880 Torrey Pines Scenic Dr
La Jolla
CA
United States
92037
Show map